The dawning of the non-cancer uses of aromatase inhibitors in gynaecology.
de Ziegler
Dominique
D
Department of Obstetrics and Gynecology, Hopital de Nyon, 1260 Nyon, Switzerland. ddeziegler@bluewin.ch
D047072:Aromatase Inhibitors; D017277:Drug Approval; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage; D043373:Follicle Stimulating Hormone, Human / Q000008:administration & dosage; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors; D006176:Gynecology / Q000379:methods*; D006801:Humans; D000077289:Letrozole; D007986:Luteinizing Hormone / Q000097:blood; D009570:Nitriles / Q000008:administration & dosage; D009865:Oocytes / Q000187:drug effects; D010062:Ovulation Induction / Q000379:methods; D011247:Pregnancy; D014230:Triazoles / Q000008:administration & dosage
D047072:Aromatase Inhibitors; D004791:Enzyme Inhibitors; D005300:Fertility Agents, Female; D043373:Follicle Stimulating Hormone, Human; D009570:Nitriles; D014230:Triazoles; D007987:Gonadotropin-Releasing Hormone; D000077289:Letrozole; D007986:Luteinizing Hormone